Go to the University of Bologna homepage
Department of Pharmacy and Biotechnology - FABIT

From the Discovery to the Approval of Elacestrant: the first oral SERD in Breast Cancer

There is no translation for this page

The information on this page is available in these languages

You may be interested in other contents of Events